evaluation of a dna vaccine for prostate cancer
Published 6 years ago • 673 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
1:30
asessing the ptvg-hp plasmid dna vaccine in patients with mcrpc
-
0:56
vaccines are a promising direction for prostate cancer immunotherapy
-
1:32
combining antigen-specific vaccination and targeted radionuclide therapy in a murine prostate model
-
1:30
vbir vaccine shows promise in prostate cancer: phase i trial results and immunotherapy potential
-
5:25
developing vaccines as a treatment for prostate cancer
-
5:54
prospect: how effective is the new prostvac vaccine against prostate cancer?
-
4:25
the impact of dna repair defects on prostate cancer
-
0:51
psa testing for prostate cancer
-
1:35
can vaccines and immune checkpoint inhibitors work together to treat prostate cancer?
-
4:44
prostate cancer update: practice-changing data?
-
5:32
ctdna abnormalities in prostate cancer: distinctions in aa versus ca patients
-
0:35
why should i consider biomarker or somatic testing?
-
4:17
dna specimen provenance assay preventing overdiagnosis of prostate cancer
-
1:47:19
genetic testing in prostate cancer webcast (2021)
-
11:18
prostate cancer screening & genetic testing: the nccn perspective
-
23:10
genetic testing and next generation dna sequencing in prostate cancer
-
4:30
will the covid-19 vaccines change my dna and ability to test for the virus?
-
0:39
future potential and challenges of adapt-001: evaluating efficacy and exploring new cancer types
-
19:27
prostate cancer: the abcs of initial evaluation